Sectoral Asset Management — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Magnolia Medical Technologiesmagnolia-medical.cominFeb 2022 · $46M
Magnolia Medical develops diagnostic devices to reduce blood culture contamination and false-positive sepsis test results for hospitals and healthcare systems.
HardwareHealthtechMedical DevicesSeattle, US
Gregory J Bullington(Executive Officer, Director)Richard Patton(Co-founder)
BoardPaul Meister(Director)
Co-investorsEvidity Health CapitalLauder PartnersRhapsody Venture PartnersVivo CapitalHealthQuest CapitalJanus Henderson Investors+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.